Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Wilberg A. Moncada-Arita"'
Autor:
Wilberg A. Moncada Arita, Eduardo Smelin Perdomo Domínguez, Astrid Yohaly Rivera Caballero, Nelson A. Espinoza‐Moreno, Mauricio E. Zavala Galeano, Barbara R. DuPont, Héctor M. Ramos‐Zaldívar
Publikováno v:
Clinical Case Reports, Vol 10, Iss 4, Pp n/a-n/a (2022)
Abstract Less than one percent of individuals with Down syndrome exhibit mosaicism, a biological phenomenon that describes an individual who has two or more genetically distinct cell lines. The percentage of mosaicism in different tissues can impact
Externí odkaz:
https://doaj.org/article/1c51cdb96ce649adb4fb2d820fdb84f5
Autor:
Héctor M. Ramos-Zaldívar, Karla G. Reyes-Perdomo, Nelson A. Espinoza-Moreno, Ernesto Tomás Dox-Cruz, Thania Camila Aguirre Urbina, Astrid Yohaly Rivera Caballero, Eduardo Smelin Perdomo Dominguez, Sofía Guadalupe Peña Calix, Joselin Michelle Monterroso-Reyes, Erick Fernando Caballero Vásquez, Tarek Sai Zelaya Ortiz, Hilbron Eduardo Rodríguez-Machado, Marcelo Andres Forgas Solis, Iveth Sebilla Silva, Mauricio Edgardo Zavala Galeano, Alejandro Antonio Morga Alvarado, Angie María Nicolle Solís Medina, Leticia M. Guerrero-Díaz, Julia E. Jiménez-Faraj, Caroll Alejandra Perelló Santos, Wilberg A. Moncada Arita, Darwing Fabricio Valdiviezo Montufar, Josué David Hernández Sabillón, Mónica L. Sorto G., Xochilt Xiomara Padilla Navarro, Victoria A. Palomo-Bermúdez, Héctor Armando Alvarenga Andino, Sandra Patricia Reyes Guzman, María Haydee Rivera Reyes, Esdras Said Medina Paz, Joselyn Rosario Alvarado Enamorado, Yenny Mariel Sabillón Sagastume, Ariadna Stephanny Mejia Rivera, Claudia Michelle Posas Sarmiento, Xenia Vanessa Jiménez Pineda, Verónica Alejandra Hernández Puerto, Josué David Portillo Landaverde, Reyes S. Sergio, Ivin Perdomo R., Josué J. Rivera, Wendy Cecilia Mendoza Girón, Karla Melissa Tróchez Sabillón, Paola Nohemy Katsumata Leiva, Karla Elizabeth Pineda Toro, Jimena A. Montes-Gambarelli, Cristhiam Flores, Edison Salas-Huenuleo, Marcelo E. Andia
BackgroundCoronavirus disease 2019 (Covid-19) active cases continue to demand the development of safe and effective treatments. This is the first clinical trial to evaluate the safety and efficacy of oral thymic peptides.MethodsWe conducted a nonrand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29adc3c961405003f197706ecb8cb101
https://doi.org/10.1101/2021.12.05.21267318
https://doi.org/10.1101/2021.12.05.21267318
Autor:
José S. Napky-Rajo, Victoria A. Palomo-Bermúdez, Amanda G. Hernández-Padilla, Nelson A. Espinoza-Moreno, Isis M. Euceda, Luis A. Leiva-Sanchez, Carlos A. Gámez-Fernández, Tulio A. Bueso-Aguilar, Aldo F. Ponce-Barahona, Edwin Francisco Herrera-Paz, Jimena A. Montes-Gambarelli, Wilberg A. Moncada-Arita, Daniel G. Martínez-Irías, Héctor M. Ramos-Zaldívar, Kevin J. Robertson, Denys A. Olivera, Karla G. Reyes-Perdomo, Julia E. Jiménez-Faraj
Publikováno v:
Journal of Medical Case Reports
Background Chromosomal region 7q21.3 comprises approximately 5.2 mega base pairs that include genes DLX5/6, SHFM1, and DYNC1I1 associated with split hand/split foot malformation 1. So far, there are reports of eight families with deletion of DYNC1I1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34f5fec842dfb194c2b05fae580654b3
https://doi.org/10.1186/s13256-016-0921-8
https://doi.org/10.1186/s13256-016-0921-8